Experiment 945333
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | SHEPHERD,FA: BURKES,RL: PAUL,KE: GOSS,PE:. (1991). A PHASE II STUDY OF 4'-EPIRUBICIN IN THE TREATMENT OF POOR-RISK KAPOSI'S SARCOMA AND AIDS.. 5(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | 26 AIDS PATIENTS WITH KAPOSI'S SARCOMA WERE USED IN THIS PHASE 2 STUDY. PATIENTS WERE TREATED FOR 22 WEEKS RECEIVING THE DRUG EVERY 3 WEEKS. 1 PATIENT ACHIEVED COMPLETE RESPONSE AND 10 ACHIEVED PARTIAL RESPONSE, 9 PATIENTS HAD STABLE DISEASE AND 5 HAD PROGRESSIVE DISEASE. TOXICITIES INCLUDED VOMITING, STOMATITIS AND HAIR LOSS. MYELOSUPPRESSION WAS THE DOSE LIMITING TOXICITY. |
| Dose amount | 90.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |